ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC18615-10mg |
|
229021-64-1 |
Arachidonoyl Cyclopropylamide
|
0 | C23H37NO | |
GC18615-5mg |
|
229021-64-1 |
Arachidonoyl Cyclopropylamide
|
0 | C23H37NO | |
GC18614-10mg |
|
225233-99-8 |
SNVP
|
0 | C10H18N2O4S | |
GC18614-5mg |
|
225233-99-8 |
SNVP
|
0 | C10H18N2O4S | |
GC18612-1mg |
|
204140-01-2 |
MMP-9/MMP-13 Inhibitor I
|
0 | C25H25N3O6S | |
GC18612-500μg |
|
204140-01-2 |
MMP-9/MMP-13 Inhibitor I
|
0 | C25H25N3O6S | |
GC18611-1mg |
|
20108-30-9 |
Fusicoccin
|
0 | C36H56O12 | |
GC18611-500μg |
|
20108-30-9 |
Fusicoccin
|
0 | C36H56O12 | |
GC18609-10mg |
|
196497-48-0 |
1-Deoxysphinganine (m18:0)
|
0 | C18H39NO | |
GC18609-5mg |
|
196497-48-0 |
1-Deoxysphinganine (m18:0)
|
0 | C18H39NO | |
GC18609-1mg |
|
196497-48-0 |
1-Deoxysphinganine (m18:0)
|
0 | C18H39NO | |
GC18608-1mg |
|
193807-60-2 |
MMP-2/MMP-9 Inhibitor II
|
0 | C21H20N2O4S | |
GC18608-500μg |
|
193807-60-2 |
MMP-2/MMP-9 Inhibitor II
|
0 | C21H20N2O4S | |
GC18607-1mg |
|
191102-79-1 |
GGTI 2133
|
0 | C27H28N4O3 | |
GC18607-500μg |
|
191102-79-1 |
GGTI 2133
|
0 | C27H28N4O3 | |
GC18605-10mg |
|
853799-77-6 |
N-(3-Hydroxyoctanoyl)-DL-homoserine lactone
|
0 | C12H21NO4 | |
GC18604-1mg |
|
168482-84-6 |
Calcein Blue AM
|
0 | C21H23NO11 | |
GC18603-50mg |
|
16662-46-7 |
(±)-Methoxyverapamil (hydrochloride)
|
0 | C28H40N2O5.HCl | |
GC18603-25mg |
|
16662-46-7 |
(±)-Methoxyverapamil (hydrochloride)
|
0 | C28H40N2O5.HCl | |
GC18603-10mg |
|
16662-46-7 |
(±)-Methoxyverapamil (hydrochloride)
|
0 | C28H40N2O5.HCl | |